Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd
Cost Eff Resour Alloc
.
2023 May 31;21(1):35.
doi: 10.1186/s12962-023-00441-z.
Authors
Makoto Kosaka
1
,
Akihiko Ozaki
2
3
,
Yudai Kaneda
4
,
Hiroaki Saito
2
,
Erika Yamashita
2
,
Anju Murayama
5
,
Hanano Mamada
2
,
Tetsuya Tanimoto
2
,
Mihajlo Jakovljevic
6
7
8
Affiliations
1
Imamura Hospital Kagoshima, Kagoshima, Japan.
2
Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
3
Department of Breast and Thryoid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
4
School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
5
School of Medicine, Tohoku University, Sendai, Miyagi, Japan.
6
Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
[email protected]
.
7
Institute of Comparative Economic Studies, Hosei University, Chiyoda-ku, Tokyo, Japan.
[email protected]
.
8
Department of Global Health Economics and Policy, University of Kragujevac, Kragujevac, Serbia.
[email protected]
.
PMID:
37259132
PMCID:
PMC10230667
DOI:
10.1186/s12962-023-00441-z
No abstract available
Publication types
Editorial